Overview

Combined Effect of Continuous and Interval in Addition to Tadalafil Drug on Erectile Dysfunction

Status:
Recruiting
Trial end date:
2021-03-30
Target enrollment:
Participant gender:
Summary
Erectile dysfunction (ED) is the persistent inability to attain and maintain a sufficient erection to permit satisfactory sexual performance. ED, a condition closely related to cardiovascular morbidity and mortality, is frequently associated with obesity. The importance of reducing cardiovascular risk factors remains fundamental to the overall vascular good health of the man, and that includes sexual vascular health. ED shares similar modifiable risks factors with coronary artery disease (CAD). Lifestyle modification that targets CAD risk factors may also lead to improvement in ED.
Phase:
N/A
Details
Lead Sponsor:
Cairo University
Treatments:
Tadalafil